HIV-1 Virologic Rebound Due to Coadministration of Divalent Cations and Bictegravir
Tóm tắt
A potential drug-drug interaction exists between divalent and trivalent cations (Ca2+, Fe3+, Mg2+, Al3+, Zn2+) and HIV-1 integrase strand transfer inhibitors (INSTIs). There are limited case reports describing the clinical significance of this potential interaction and none to our knowledge identifying zinc co-administration with INSTIs. In this report we present a patient taking bictegravir/emtricitabine/tenofovir alafenamide who became viremic after ingesting zinc and calcium supplements and later was able to obtain virologic re-suppression after discontinuing supplements. This case represents a potential significant drug interaction between a commonly prescribed antiretroviral drug class and readily available over-the-counter divalent cation products.
Tài liệu tham khảo
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 15 May 2020 [Table 6a, Table 21d].
Hajimahdi Z, Zarghi A. Progress in HIV-1 integrase inhibitors: a review of their chemical structure diversity. Iran J Pharm Res. 2016;15(4):595–628.
Song I, Borland J, Arya N, Wynne B, Piscitelli S. Pharmacokinetics of dolutegravir when administered with mineral supplements in healthy adult subjects. J Clin Pharmacol. 2015;55(5):490–6.
Krishna R, East L, Larson P, et al. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir. J Pharm Pharmacol. 2016;68(11):1359–65.
Forst TM, Dinges WL. Coadministration of divalent cation mineral supplements causes CART virologic failure and hiv mutagenesis: a Case Study. Clin J HIV AIDS. 2018;2(1):26–7.
Tivicay (dolutegravir) [package insert]. Research Triangle Park, NC: GlaxoSmithKline; August 2013.
Triumeq (dolutegravir/abacavir/lamivudine) [package insert]. Research Triangle Park, NC: GlaxoSmithKline; August 2014.
Dovato (dolutegravir/lamivudine) [package insert]. Research Triangle Park, NC: GlaxoSmithKline; April 2019.
Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir desoproxil fumarate) [package insert]. Foster City, CA: Gilead Sciences, Inc.; August 2017.
Genvoya (elvitegravir. cobicistat, emtricitabine, tenofovir alafenamide) [package insert]. Foster City, CA: Gilead Sciences, Inc.; December 2016.
Biktarvy (bictegravir, emtricitabine, tenofovir alafenamide) [package insert]. Foster City, CA: Gilead Sciences, Inc; February 2018.
Isentress (raltegravir) [package insert]. Whitehouse Station, NJ: Merck & Co., Inc.; August 2013.
Zinc. In: Natural Medicines Comprehensive Database. Somerville, MA: Natural Standard. [Published 2020]. https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=982. Accessed 20 Jan 2020
Lodha R, Shah N, Mohari N, et al. Immunologic effect of zinc supplementation in HIV-infected children receiving highly active antiretroviral therapy: a randomized, double-blind, placebo-controlled trial. J Acquir Immune Defic Syndr. 2014;66(4):386–92.
Motswagole BS, Mongwaketse TC, Mokotedi M, et al. The efficacy of micronutrient-fortified sorghum meal in improving the immune status of HIV-positive adults. Ann Nutr Metab. 2013;62(4):323–30.
Ndeezi G, Tylleskar T, Ndugwa CM, Tumwine JK. Effect of multiple micronutrient supplementation on survival of HIV-infected children in Uganda: a randomized, controlled trial. J Int AIDS Soc. 2010;13:18.
Sundaram M, Saghayam S, Priya B, et al. Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India. Int J Infect Dis. 2008;12(6):e61–6.
Green JA, Lewin SR, Wightman F, Lee M, Ravindran TS, Paton NI. A randomised controlled trial of oral zinc on the immune response to tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis. 2005;9(12):1378–84.
Villamor E, Aboud S, Koulinska IN, et al. Zinc supplementation to HIV-1-infected pregnant women: effects on maternal anthropometry, viral load, and early mother-to-child transmission. Eur J Clin Nutr. 2006;60(7):862–9.
Bobat R, Coovadia H, Stephen C, et al. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet. 2005;366(9500):1862–7.
Fawzi WW, Villamor E, Msamanga GI, et al. Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania. Am J Clin Nutr. 2005;81(1):161–7.
Reich EN, Church JA. Oral zinc supplementation in the treatment of HIV-infected children. Pediatr AIDS HIV Infect. 1994;5(6):357–60.
Baum MK, Lai S, Sales S, Page JB, Campa A. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Clin Infect Dis. 2010;50(12):1653–60.
Zhao F, Wang Z, Li WJ. Impact of micronutrients on immunocyte and microelements status among people living with HIV. Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30(5):452–4.
Asdamongkol N, Phanachet P, Sungkanuparph S. Low plasma zinc levels and immunological responses to zinc supplementation in HIV-infected patients with immunological discordance after antiretroviral therapy. Jpn J Infect Dis. 2013;66(6):469–74.
Moyle G, Else L, Jackson A, et al. Coadministration of atazanavir-ritonavir and zinc sulfate: impact on hyperbilirubinemia and pharmacokinetics. Antimicrob Agents Chemother. 2013;57(8):3640–4.
Bunupuradah T, Ubolyam S, Hansudewechakul R, et al. Correlation of selenium and zinc levels to antiretroviral treatment outcomes in Thai HIV-infected children without severe HIV symptoms. Eur J Clin Nutr. 2012;66(8):900–5.
Gnatienko N, Freiberg MS, Blokhina E, et al. Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia. HIV Clin Trials. 2018;19(3):101–11.
Jung S, Kim MK, Choi BY. The relationship between zinc status and inflammatory marker levels in rural Korean adults aged 40 and older. PLoS One. 2015;10(6):e0130016.